Meristem Family Wealth’s NeoGenomics NEO Stock Holding History

Meristem Family Wealth’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-14,476	Closed	-$190K	–	150
2018 Q2	$190K	Hold	14,476	–	–	0.07%	137
2018 Q1	$118K	Hold	14,476	–	–	0.04%	127
2017 Q4	$128K	Buy	+14,476	New	+$134K	0.05%	120
2017 Q3	–	Sell	-11,325	Closed	-$101K	–	113
2017 Q2	$101K	Hold	11,325	–	–	0.04%	103
2017 Q1	$89K	Hold	11,325	–	–	0.04%	103
2016 Q4	$97K	Buy	+11,325	New	+$97K	0.04%	105
2016 Q2	–	Sell	-14,712	Closed	-$99K	–	108
2016 Q1	$99K	Hold	14,712	–	–	0.04%	110
2015 Q4	$116K	Hold	14,712	–	–	0.05%	111
2015 Q3	$84K	Buy	14,712 +3,938	+37%	+$24.4K	0.04%	53
2015 Q2	$58K	Hold	10,774	–	–	0.03%	112
2015 Q1	$50K	Hold	10,774	–	–	0.02%	117
2014 Q4	$45K	Hold	10,774	–	–	0.02%	115
2014 Q3	$56K	Buy	+10,774	New	+$55.3K	0.02%	110

Other funds holding NEO

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Meristem Family Wealth's NEO Position: Q3 2018 in Review

Meristem Family Wealth sold out of NeoGenomics (NEO) in Q3 2018, closing a stake of 14,476 shares — an estimated $190K sold.

Meristem Family Wealth first reported a position in NEO in Q3 2014 and held it in 13 quarters. The position peaked at $190K in Q2 2018. 168 funds tracked by Wall St. Rank hold NEO as of Q3 2018.

Meristem Family Wealth reported no remaining NeoGenomics position as of Q3 2018 after selling out during the quarter.
Meristem Family Wealth sold 14,476 NeoGenomics shares in Q3 2018, an estimated $190K.
Meristem Family Wealth first reported a position in NeoGenomics in Q3 2014 and held it in 13 quarters.
Meristem Family Wealth's NeoGenomics position peaked at $190K in Q2 2018.
168 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2018.

Based on Meristem Family Wealth's 13F filing for Q3 2018, filed 20 Nov 2018.